Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Urologic Oncology|April 25, 2015
Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and youngerOrazio Caffo, Cinzia Ortega, Giuseppe Di Lorenzo, et al.
Future Oncology (London, England)|January 19, 2016
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancerAntonello Veccia, Orazio Caffo, Ugo De Giorgi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2021
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trialOrazio Caffo, Cinzia Ortega, Franco Nolè, et al.
European Urology|December 3, 2014
Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre StudyOrazio Caffo, Ugo De Giorgi, Lucia Fratino, et al.
Pageof 2